PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-243

  1. 9,819 Posts.
    lightbulb Created with Sketch. 1249
    Thanks Mozz IMO you shouldn't even bother justifying yourself or responding to "rose colour" comments given you've always come across balances and pragmatic.

    My 5c worth. It's been exceptional grating on many of us to see PR continue to award himself an exceptional generous package. He alone has drained shareholder equity >$20M (not including his 20M share holding). Amos confirmed they hadn't benchmarked REM until more recently and then arrived at $1M base. The effort they then went to via amending AGM resolutions in order to further feed from the trough was insulting given he also knew in advance of the CR and likely cashflow projections into year end.

    He hasn't endeared himself to what the market now requires from a top notch CEO/Chair. You get awarded the big $$$ but ONLY after your look after shareholders and your customers first. Refer to MQG for example.

    As a result we now have a CEO/Chair on probably the highest CEO-Chair package/EV on the ASX, despite some serious concerns on our ability to fund P3. In fact even with the 20% discount I can't see any list ASX CEO anywhere near the same multiple.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.